BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29097160)

  • 1. Clinical Practice Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia (CLL) in The Netherlands.
    Kersting S; Neppelenbroek SIM; Visser HPJ; van Gelder M; Levin MD; Mous R; Posthuma W; van der Straaten HM; Kater AP
    Clin Lymphoma Myeloma Leuk; 2018 Jan; 18(1):52-57. PubMed ID: 29097160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic lymphocytic leukemia: pathophysiology and current therapy].
    Takizawa J
    Rinsho Ketsueki; 2017; 58(5):471-479. PubMed ID: 28592762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic markers and standard management of chronic lymphocytic leukemia.
    Stilgenbauer S
    Hematology Am Soc Hematol Educ Program; 2015; 2015():368-77. PubMed ID: 26637745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Treatment of Chronic Lymphocytic Leukemia.
    Jamroziak K; Puła B; Walewski J
    Curr Treat Options Oncol; 2017 Jan; 18(1):5. PubMed ID: 28185174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dutch guidelines for diagnosis and treatment of chronic lymphocytic leukaemia 2011.
    Kater AP; Wittebol S; Chamuleau ME; van Gelder M; J van Oers MH; Hovon CLL Working Party
    Neth J Med; 2011 Oct; 69(10):422-9. PubMed ID: 22058261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Influences the Choice of Ibrutinib-Rituximab vs Classic Chemoimmunotherapy for Chronic Lymphocytic Leukemia?
    Bravaccini S; Martinelli G; Cerchione C
    Cell Transplant; 2020; 29():963689720950209. PubMed ID: 32907382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dutch guidelines for the diagnosis and treatment of chronic lymphocytic leukaemia.
    Dutch/Belgium HOVON CLL working group
    Neth J Med; 2016 Feb; 74(2):68-74. PubMed ID: 26951351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State-of-the-Art Treatment and Novel Agents in Chronic Lymphocytic Leukemia.
    Cramer P; Hallek M; Eichhorst B
    Oncol Res Treat; 2016; 39(1-2):25-32. PubMed ID: 26890007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current perspectives on the role of chemotherapy in chronic lymphocytic leukemia.
    Wendtner CM; Gregor M
    Leuk Lymphoma; 2018 Feb; 59(2):300-310. PubMed ID: 28565930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment approach for elderly and unfit patients with chronic lymphocytic leukemia.
    Innocenti I; Autore F; Pasquale R; Morelli F; Efremov DG; Laurenti L
    Expert Rev Hematol; 2017 Dec; 10(12):1069-1076. PubMed ID: 29082795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitting new treatments for chronic lymphocytic leukemia against old ones: how do they fare?
    Shvidel L; Berrebi A
    Expert Rev Hematol; 2016 Mar; 9(3):245-54. PubMed ID: 26613391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment.
    Hallek M
    Am J Hematol; 2015 May; 90(5):446-60. PubMed ID: 25908509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial therapy of chronic lymphocytic leukemia.
    Eichhorst B; Cramer P; Hallek M
    Semin Oncol; 2016 Apr; 43(2):241-50. PubMed ID: 27040702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of chronic lymphocytic leukemia.
    Stilgenbauer S; Furman RR; Zent CS
    Am Soc Clin Oncol Educ Book; 2015; ():164-75. PubMed ID: 25993154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Therapies for Chronic Lymphocytic Leukemia: A Canadian Perspective.
    Owen C; Assouline S; Kuruvilla J; Uchida C; Bellingham C; Sehn L
    Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):627-634.e5. PubMed ID: 26416145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving Strategies for the Treatment of Chronic Lymphocytic Leukemia in the Upfront Setting.
    Bachow SH; Lamanna N
    Curr Hematol Malig Rep; 2016 Feb; 11(1):61-70. PubMed ID: 26951237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic lymphocytic leukemia (CLL)-Then and now.
    Rai KR; Jain P
    Am J Hematol; 2016 Mar; 91(3):330-40. PubMed ID: 26690614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in first-line treatment of chronic lymphocytic leukemia: current recommendations on management and first-line treatment by the German CLL Study Group (GCLLSG).
    Cramer P; Langerbeins P; Eichhorst B; Hallek M
    Eur J Haematol; 2016 Jan; 96(1):9-18. PubMed ID: 26332019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
    Brugiatelli M; Bandini G; Barosi G; Lauria F; Liso V; Marchetti M; Mauro FR; Meloni G; Zinzani PL; Tura S; ; ;
    Haematologica; 2006 Dec; 91(12):1662-73. PubMed ID: 17145603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis, treatment and supportive management of chronic lymphocytic leukemia: recommendations of the Dutch HOVON CLL working group.
    Raa DGT; van der Straten L; van Gelder M; Kersting S; Levin MD; Mous R; van der Straaten HM; Nijziel MR; van der Spek E; Posthuma EFM; Visser HPJ; van der Klift M; de Heer K; Bellido M; Doorduijn JK; Bruns AHW; Raijmakers RAP; Kater AP;
    Leuk Lymphoma; 2022 Oct; 63(10):2276-2289. PubMed ID: 35737364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.